All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Donsumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023001%3A_____%2F14%3A00059141" target="_blank" >RIV/00023001:_____/14:00059141 - isvavai.cz</a>

  • Result on the web

    <a href="http://orbis.lfhk.cuni.cz/Acta_Medica/2014/2014_30.pdf" target="_blank" >http://orbis.lfhk.cuni.cz/Acta_Medica/2014/2014_30.pdf</a>

  • DOI - Digital Object Identifier

Alternative languages

  • Result language

    angličtina

  • Original language name

    Donsumab associated with bone density increase and clinical improvement in a long-term hemodialysis patient. Case report and review of the literature

  • Original language description

    Denosumab is a full length human monoclonal antibody binding to the receptor activator of nuclear factor kappa-B ligand (RANKL), mimicking the action of osteoprotegerin (OPG, natural decoy receptor of RANKL) and representing a novel therapy of osteoporosis, approved by FDA in 2010 (1). By its action on RANKL, denosumab reduces the signal that is essential for osteoclasts formation, maturation, function and survival. RANKL inhibition has no effect on osteoblasts. Denosumab is not cleared by the kidneys.In chronic kidney disease (CKD) dose adjustment of denosumab is not required but calcium and vitamin D supplementation is strongly recommended (2). So far, only few case reports or very limited case series describing the experience with denosumab in CKDhave been published. They all stopped the therapy after single dose because of hypocalcemia (3, 4, 5, 6, 7, 8) (Table 1). We present a case of successful treatment of osteoporosis in a young hemodialysis patient with repeated denosumab do

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FE - Other fields of internal medicine

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Acta medica

  • ISSN

    1211-4286

  • e-ISSN

  • Volume of the periodical

    57

  • Issue of the periodical within the volume

    1

  • Country of publishing house

    CZ - CZECH REPUBLIC

  • Number of pages

    5

  • Pages from-to

    30-34

  • UT code for WoS article

  • EID of the result in the Scopus database